Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas E Witzig

Showing results (41-50 of 387) with videos related to

Pageof 39
Sort By:
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 13, 2011
Orbital inflammation with IgG4-positive plasma cells: manifestation of IgG4 systemic diseaseJosé Antonio Plaza, James A Garrity, Ahmet Dogan, et al.
Blood|July 31, 2009
Inhibition of histone deacetylase overcomes rapamycin-mediated resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling through mTORC2Mamta Gupta, Stephen M Ansell, Anne J Novak, et al.
Cancers|October 27, 2022
The Tumor Suppressor Protein TRAF3 Modulates GSK3 Activity and Susceptibility of B Lymphoma Cells to GSK3 InhibitionEmma L Hornick, Laura L Stunz, Shakoora Sabree, et al.
Experimental Hematology|June 21, 2005
PS-341-mediated selective targeting of multiple myeloma cells by synergistic increase in ionizing radiation-induced apoptosisApollina Goel, Angela Dispenzieri, Philip R Greipp, et al.
Leukemia & Lymphoma|February 12, 2014
Recent advances in mantle cell lymphoma: report of the 2013 Mantle Cell Lymphoma Consortium WorkshopLeo I Gordon, Steven H Bernstein, Pedro Jares, et al.
British Journal of Haematology|March 6, 2008
Anti-CD20 monoclonal antibody therapy in multiple myelomaPrashant Kapoor, Patricia T Greipp, William G Morice, et al.
Leukemia & Lymphoma|February 1, 2013
Recent advances in mantle cell lymphoma: report of the 2012 Mantle Cell Lymphoma Consortium WorkshopMichael E Williams, Steven H Bernstein, Pedro Jares, et al.
American Journal of Hematology|January 7, 2009
Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphomaLuis F Porrata, Kay Ristow, Thomas M Habermann, et al.
Blood Cancer Journal|May 18, 2019
Integrating precision medicine through evaluation of cell of origin in treatment planning for diffuse large B-cell lymphomaGrzegorz S Nowakowski, Tatyana Feldman, Lisa M Rimsza, et al.
Blood|November 11, 2010
Immunosuppressive CD14+HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphomaYi Lin, Michael P Gustafson, Peggy A Bulur, et al.
Pageof 39

Showing results (41-50 of 387) with videos related to

Sort By:
Pageof 39
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 13, 2011
Orbital inflammation with IgG4-positive plasma cells: manifestation of IgG4 systemic diseaseJosé Antonio Plaza, James A Garrity, Ahmet Dogan, et al.
Blood|July 31, 2009
Inhibition of histone deacetylase overcomes rapamycin-mediated resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling through mTORC2Mamta Gupta, Stephen M Ansell, Anne J Novak, et al.
Cancers|October 27, 2022
The Tumor Suppressor Protein TRAF3 Modulates GSK3 Activity and Susceptibility of B Lymphoma Cells to GSK3 InhibitionEmma L Hornick, Laura L Stunz, Shakoora Sabree, et al.
Experimental Hematology|June 21, 2005
PS-341-mediated selective targeting of multiple myeloma cells by synergistic increase in ionizing radiation-induced apoptosisApollina Goel, Angela Dispenzieri, Philip R Greipp, et al.
Leukemia & Lymphoma|February 12, 2014
Recent advances in mantle cell lymphoma: report of the 2013 Mantle Cell Lymphoma Consortium WorkshopLeo I Gordon, Steven H Bernstein, Pedro Jares, et al.
British Journal of Haematology|March 6, 2008
Anti-CD20 monoclonal antibody therapy in multiple myelomaPrashant Kapoor, Patricia T Greipp, William G Morice, et al.
Leukemia & Lymphoma|February 1, 2013
Recent advances in mantle cell lymphoma: report of the 2012 Mantle Cell Lymphoma Consortium WorkshopMichael E Williams, Steven H Bernstein, Pedro Jares, et al.
American Journal of Hematology|January 7, 2009
Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphomaLuis F Porrata, Kay Ristow, Thomas M Habermann, et al.
Blood Cancer Journal|May 18, 2019
Integrating precision medicine through evaluation of cell of origin in treatment planning for diffuse large B-cell lymphomaGrzegorz S Nowakowski, Tatyana Feldman, Lisa M Rimsza, et al.
Blood|November 11, 2010
Immunosuppressive CD14+HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphomaYi Lin, Michael P Gustafson, Peggy A Bulur, et al.
Pageof 39